Search results
‘Unusual’ cancers emerged after the pandemic. Doctors ask if covid is to blame.
Washington Post· 7 days agoPatel looked forward to his team’s Friday lunches. It was 2021, a year into the coronavirus...
Oregon to receive $15 million in settlement over baby powder lawsuit
Daily Montanan via Yahoo News· 1 hour agoOregon will receive $15 million from Johnson & Johnson to settle allegations that the pharmaceutical...
More rare cancers being diagnosed after the pandemic
Becker’s Hospital Review· 7 days agoSince the 1960s, scientists have estimated that 15% to 20% of all cancers originate from infectious agents, such as HPV, Epstein-Barr and hepatitis B. It's ...
Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates
Zacks via Yahoo Finance· 6 days agoThe study is evaluating the safety, tolerability and efficacy of tobevibart and investigational...
Can statins help prevent cancer? New study offers clues
MedicalNewsToday via AOL· 4 days agoA recent study found that using the statin pitavastatin may assist in blocking a particular...
These Are The 5 Biggest Early Warning Signs Of Liver Damage
BuzzFeed via Yahoo News· 3 days agoDouglas Weine, a gastroenterologist at Hackensack Meridian Health Center. Liver conditions include...
ARUP blood services said updated donation guidelines help donors and patients
KSL TV Utah· 6 days agoThe organization is the sole provider of blood to the University of Utah and Huntsman Cancer...
CMDHD launches new hepatitis C treatment program
Midland Daily News· 3 days agoCentral Michigan District Health Department launched a new hepatitis C treatment program, aimed at providing accessible and effective treatment to individuals in the community ...
Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with...
KSAN - KLST San Angelo· 2 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related ...
Gilead Announces New England Journal of Medicine Publication of Data that Demonstrate Bulevirtide...
Morningstar· 7 days agoGilead Announces New England Journal of Medicine Publication of Data that Demonstrate Bulevirtide with PegIFN Achieved Post-Treatment Undetectable HDV RNA - Phase 2b Data Presented at EASL and Published in NEJM Show Potential for Bulevirtide 10 mg